Biogen is buying up an immune drug developer for $1.8 billion
qz.com › biogen-hi-bio-1851493202
This story seems to be about:
This story seems to be about:
Biotechnology giant Biogen said on Wednesday that it is acquiring immune drug developer Human Immunology Biosciences (HI-Bio) to boost its late-stage pipeline and immunology portfolio. Biogen has agreed to a $1.15 billion upfront payment and up to $650 million in additional payments if certain milestones are met.